APA (7th ed.) Citation

E, T., T, G., P, S., C, T., T, A., & AJ, K. (2025). Immunogenicity of a CXCL8-based biopharmaceutical drug candidate in comparison to its wildtype form. Frontiers in immunology, 16, 1679409. https://doi.org/10.3389/fimmu.2025.1679409

Chicago Style (17th ed.) Citation

E, Talker, Gerlza T, Stas P, Trojacher C, Adage T, and Kungl AJ. "Immunogenicity of a CXCL8-based Biopharmaceutical Drug Candidate in Comparison to Its Wildtype Form." Frontiers in Immunology 16 (2025): 1679409. https://doi.org/10.3389/fimmu.2025.1679409.

MLA (9th ed.) Citation

E, Talker, et al. "Immunogenicity of a CXCL8-based Biopharmaceutical Drug Candidate in Comparison to Its Wildtype Form." Frontiers in Immunology, vol. 16, 2025, p. 1679409, https://doi.org/10.3389/fimmu.2025.1679409.